Recce Pharmaceuticals Aktie News & Pressemeldungen

Notícias Eulerpool Recce Pharmaceuticals

09/10/2024, 12:38:26

Recce Pharmaceuticals: Ein bedeutender Schritt in der Behandlung bakterieller Hautinfektionen

05/11/2024, 11:26:15

Fortschritte in der Behandlung bakterieller Hautinfektionen: Recce Pharmaceuticals in Phase-II-Studie auf Erfolgskurs

11/11/2024, 13:00:26

Revolutionäre Fortschritte bei der Behandlung des diabetischen Fußsyndroms mit RECCE® 327

10/12/2024, 10:20:50

Recce Pharmaceuticals erreicht bedeutenden Meilenstein mit Phase-3-Studie in Indonesien

17/02/2025, 14:14:19

Medizinische Innovation: Recce Pharmaceuticals begeistert mit Phase-II-Ergebnissen

Recce Pharmaceuticals Notícias de ações

Recce Pharmaceuticals é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Recce Pharmaceuticals nós reunimos aqui.

27 de fevereiro ·
Yahoo
Recce Pharmaceuticals Granted Japanese Patent for RECCE® Anti-Infectives
10 de dezembro ·
Yahoo
Recce Pharmaceuticals Receives Approval from Indonesia’s Drug and Food Authority for Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections
1 de dezembro ·
Yahoo
Investors in Recce Pharmaceuticals (ASX:RCE) have seen notable returns of 68% over the past five years
27 de novembro ·
Yahoo
Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti-Infectives
12 de novembro ·
Yahoo
Recce Pharmaceuticals Receives Ethics Approval in Indonesia to Commence Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections
6 de novembro ·
Yahoo
Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
10 de outubro ·
Yahoo
Recce Pharmaceuticals Announces Recruitment Passes Halfway in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
6 de agosto ·
Yahoo
Recce Pharmaceuticals Announces Successful Completion of Share Purchase Plan
10 de julho ·
Yahoo
Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
1 de julho ·
Yahoo
Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327

Recce Pharmaceuticals Ações Comunicados de Imprensa

Recce Pharmaceuticals publica regularmente na página da empresa notícias que são relevantes para os investidores.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Assinatura por 2 € / mês

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan